Session Details

U058 Latino Skin, Hair, and Aesthetics: Practical, Evidence-Based Strategies for Safer Outcomes

Sun, Mar 21, 8:00 AM - 9:00 AM
1 CME Available Focus Session NEW

DESCRIPTION

The Latino population represents approximately 19% of the U.S. population and is one of the fastest-growing and most diverse patient groups in dermatologic practice. Globally, Latino populations reflect broad genetic, geographic, cultural, and phenotypic diversity, spanning a wide range of skin phototypes, pigmentation patterns, hair textures, inflammatory responses, and aesthetic goals. Latino skin should not be approached as a single phototype or treatment category. Rather, clinicians must recognize the limitations of relying solely on the Fitzpatrick classification and incorporate individualized risk assessment, including baseline pigmentation, tendency toward post-inflammatory hyperpigmentation, scar formation, cosmetic practices, and treatment expectations. This course will provide practical, evidence-based guidance for optimizing medical, procedural, and aesthetic dermatologic care in Latino patients. Faculty will address pigmentation disorders, lasers and energy-based devices, injectables, aging patterns, hair diversity, scarring, and body aesthetics, with an emphasis on risk stratification, complication prevention, culturally informed consultation, and treatment planning.

LEARNING OBJECTIVES

1.

Apply individualized clinical risk assessment beyond Fitzpatrick skin type when evaluating Latino patients for medical, procedural, and aesthetic dermatologic treatments.

2.

Identify common dermatologic and aesthetic concerns in Latino patients, including pigmentary disorders, hair and scalp conditions, scarring, aging patterns, and cellulite, and describe evidence-based management strategies

3.

Optimize procedural safety and outcomes in Latino patients by adapting treatment planning for lasers, energy-based devices, injectables, scar management, and body aesthetic procedures

SCHEDULE

8:00 AM

Latino Skin Beyond Fitzpatrick: Clinical Risk Assessment and Stratification

Edward L. Lain, MD, FAAD

8:08 AM

Aging in Latino Skin: Patterns and Implications for Treatment Planning

8:16 AM

Pigmentation Disorders in Latino Skin: Melasma, PIH, and Complication Prevention

Cesar Fernando Gonzalez, MD, IFAAD

8:24 AM

Laser and Energy-Based Devices in Latino Skin: Safety and Optimization

Valeria Campos, MD, IFAAD

8:32 AM

Injectables in Latino Patients: Technique Adjustments and Ethnic Considerations

8:40 AM

Brazilian Body Aesthetics: A Scientific Perspective on Cellulite Treatment

Doris M. Hexsel, MD, IFAAD

8:48 AM

Panel Discussion and Audience Q&A

Suleima Arruda, MD, IFAAD

DIRECTOR

Suleima Arruda, MD, IFAAD

Suleima Arruda, MD, IFAAD

Sadick Research Group

SPEAKERS

Valeria Campos, MD, IFAAD

Valeria Campos, MD, IFAAD

Jundiai Medical School

Cesar Fernando Gonzalez, MD, IFAAD

Cesar Fernando Gonzalez, MD, IFAAD

Medical Director, International Melasma Society (Sinmelasma), Bogotá, Colombia, SouthAmerica

Doris M. Hexsel, MD, IFAAD

Doris M. Hexsel, MD, IFAAD

Hexsel Dermatologic Clinics - Private Clinics Rio de Janeiro and Porto Alegre, Brazil.

Edward L. Lain, MD, FAAD

Edward L. Lain, MD, FAAD

Sanova Dermatology

DISCLOSURES

Suleima Arruda, MD, IFAAD

No financial relationships exist with ineligible companies.

Valeria Campos, MD, IFAAD

Avene – Advisory Board(Fees); Bioderma – Advisory Board(Fees); L'Oréal France – Advisory Board(Fees); LMG – Advisory Board(Equipment); Vydence Medical – Speaker(Equipment);

Doris M. Hexsel, MD, IFAAD

Baiersdorf Eucerin – Speaker(Fees); Galderma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Rennova – Speaker(Fees);

Edward L. Lain, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); AiViva BioPharma, Inc. – Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Fees); Almirall – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Speaker(Honoraria); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); AstraZeneca – Investigator(Grants/Research Funding); Athenix – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Advisory Board(Honoraria); Biofrontera – Advisory Board(Honoraria), Investigator(Grants/Research Funding); BMS – Investigator(Grants/Research Funding); Brickell Biotech, Inc. – Investigator(Grants/Research Funding); Bristol Myers Squibb – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Speaker(Fees); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Cellceutix – Investigator(Grants/Research Funding); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Cutera, Inc. – Consultant (1099 relationship)(Fees); Dermavant Sciences, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Fees); Dow Pharmaceutical Sciences, Inc. – Investigator(Grants/Research Funding); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eli Lilly – Advisory Board(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Estee Lauder – Consultant (1099 relationship)(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Speaker(Honoraria); Galderma USA – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Highlightll Pharmaceutical – Investigator(Grants/Research Funding); Incyte – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(Grants/Research Funding), Speaker(Honoraria); janssen – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Kadmon Corporation, LLC – Investigator(Grants/Research Funding); L'Oreal – Consultant (1099 relationship)(Fees); La Roche-Posay Laboratorie Pharmaceutique – Speaker(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Medimmune – Investigator(Grants/Research Funding); Menlo Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Moleculin LLC – Stockholder(Stock); Nektar Therapeutics – Investigator(Grants/Research Funding); Neothetics – Investigator(Grants/Research Funding); Nielsen Holdings N.V – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ortho Dermatologics – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Ourself – Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Promius Pharma, LLC – Speaker(Honoraria); Q32 Bio Inc. – Investigator(Grants/Research Funding); Regenx – Investigator(Grants/Research Funding); Sebacia, Inc. – Investigator(Grants/Research Funding); Sente Labs – Consultant (1099 relationship)(Fees); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Valeant Pharmaceuticals North America LLC – Investigator(Grants/Research Funding); Vanda Pharmaceuticals Inc. – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Investigator(Grants/Research Funding);